This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundAn increased risk of recurrent stroke is noted in patients with atrialfibrillation despite direct oral anticoagulant (DOAC) use. 0.45] for rivaroxaban), and a 69% to 83% reduced risk of net composite outcomes (aHR, 0.25 [95% CI, 0.18–0.35] We identified 3759 patients with DOAC failure. 0.41] for rivaroxaban).ConclusionsIn
Background:While anticoagulation is crucial for atrialfibrillation (AF) patients to prevent ischemic events, those with thrombocytopenia have a potential increased risk of bleeding. The primary outcome was all-cause inpatient mortality.
Objective Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrialfibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes.
Introduction:Atrial fibrillation (AF) and cancer are both independently associated with worse outcomes in patients with acute ischemic stroke. Few studies have evaluated the impact of AF on outcomes of cancer-related stroke. The primary outcome was in-hospital mortality. The primary exposure was a diagnosis of AF.
years]) admitted to the China Chest Pain Center Database between 2016 and 2021. The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models.
Despite guideline recommendations for complete device removal, disparities in healthcare access and resource availability between urban and rural settings may influence patient outcomes. This study aims to evaluate ruralurban disparities in the management and outcomes of patients hospitalized with CIED infections. in rural hospitals.
This led to the development of LAAO devices which serve to occlude the left atrial appendage, a small portion of the left atrium where up to 91% of the AF-related thrombi form. Oral Anticoagulation, often necessary for the treatment of patients with AF presents a problem for patients at high risk for bleeding.
Introduction:The CHA2DS2-VASC score is used to predict stroke in people with atrialfibrillation (AF). Outcomes included health-related quality of life (HRQoL) at 90-180 days post-stroke/TIA; and all-cause mortality and hospital readmissions (all-cause, cardiovascular disease) within 1 year post-stroke/TIA.
Atrialfibrillation is also a predictor of worse outcomes in this case (Alborzi). 2016, April 13). RBBB in blunt chest trauma seems to be indicative of several RV injury. In patient's at risk, physical activity should be limited for several months after the injury. References Alborzi, Z., Zangouri, V., Ghahramani, Z.,
Though MT and DC in ischemic stroke have been studied independently, the outcomes of patients who undergo both procedures is unknown. Younger age (p < 0.001), non-white race (p < 0.001), a higher NIHSS (p < 0.001), and lower rates of atrialfibrillation were independently associated with DC after MT.
Background:Cancer is associated with an increased risk for atrialfibrillation. However, there are no existing data supporting an independent relationship between cancer and atrial cardiopathy, another atrial pathology associated with increased acute ischemic stroke (AIS) risk. The study exposure was active cancer.
The prevalence of atrialfibrillation was significantly lower in equol producers than that in non-producers (26.3% Discussion:CES, atrialfibrillation, and clinical outcome may be influenced by equol-producing status. p=0.04) among patients with ischemic stroke.
ABSTRACT Background Left atrial (LA) remodeling plays a significant role in the progression of atrialfibrillation (AF). Although LA wall thickness (LAWT) has emerged as an indicator of structural remodeling, its impact on AF outcomes remains unclear. In all cases, a pre-ablation CT was performed within less than 48 h.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. Estimates of current and future incidence and prevalence of atrialfibrillation in the U.S.
BackgroundMeta‐analyses of large clinical trials investigating SGLT2 (sodium‐glucose cotransporter‐2) inhibitors have suggested their protective effects against atrialfibrillation in patients with type 2 diabetes. An active‐comparator, new‐user design was used, and the 2 groups of patients were matched using propensity scores.
Objective To evaluate adherence and adherence consistency to the handheld ECG device-based screening protocol and their association with adverse cerebral and cardiovascular outcomes in two systematic atrialfibrillation (AF) screening programmes. to 1.51), p=0.001), including stroke (HR 1.68 (1.22 to 2.19), p<0.001).
Background:Patients with atrialfibrillation were excluded from clinical trials evaluating carotid artery stent(CAS) or carotid endarterectomy (CEA).We Background:Patients with atrialfibrillation were excluded from clinical trials evaluating carotid artery stent(CAS) or carotid endarterectomy (CEA).We versus 18.8%
Background The impact of early rhythm control (ERC) combined with healthy lifestyle (HLS) on the risk of ischemic stroke in elderly patients with atrialfibrillation (AF) remains unaddressed. Objective To evaluate the impact of combined ERC and HLS on the risk of stroke in elderly patients with new-onset AF.
Predictor variables for mortality were selected based upon previous studies of incidence and outcomes of CVT and biological plausibility.6–8 Trend analysis was completed using Joinpoint regression.ResultsFrom 2016 to 2020, the incidence of CVT increased from 24.34 in univariable regression. annually for White patients, 16.1%
Among 475 patients with cardiac sarcoidosis, 119 (25.1%) were isolated cardiac sarcoidosis (iCS) based on the 2016 Japanese Circulation Society criteria. iCS was diagnosed according to the 2016 Japanese Circulation Society (JCS) guidelines. months, 141 primary outcomes (29.7%) occurred. During a median follow-up of 42.3
BACKGROUND:There is limited information on the delivery of acute stroke therapies and secondary preventive measures and clinical outcomes over time in young adults with acute ischemic stroke. The observation period was divided into 4 epochs: 2008 to 2010, 2011 to 2013, 2014 to 2016, and 2017 to 2019. men, 71.9%) were registered.
times more likely to have a favorable outcome than those who do not achieve this goal. The final model included 1,790 patients with complete data.Results:Overall the predicted probability of 90 day MRS </= 2 was 43% in patients with DTD</=90 compared with only 32% of patients with DTD>90. p = 0.90, 95% CI = [-0.9,
This study aims to address this gap by examining the association between MA and 90-day AIS readmission.Methods:Using the National Readmission Database between 2016 and 2019, we identified patients admitted with a principal or non-principal diagnosis of migraine. The primary outcome was subsequent AIS admission within 90 days.
Many studies have aimed to determine if heart failure (HF) is an independent risk factor in the development of AIS, but there is a paucity of literature describing the interventions and functional outcomes in this group of patients. Additionally, CM‐HF patients had higher rates of medical comorbidities such as atrialfibrillation (43.6%
Outcomes included favorable disposition (discharged to home) and in-hospital mortality.Results:Among 68,975 of stroke MT with recorded NIHSS during the study period (51.1% Favorable outcome was achieved in 23.6% Further studies are needed to improve outcomes in this subset of patients. women; mean age, 69.1 [SD, 5.96], P=0.02).Conclusions:In
However, none of the formulas have proven to be definitively better than another and none are well correlated with outcomes or events! Rate correction should not be used when RR interval has large variability, as in atrialfibrillation. Correlation of QT Interval Correction Methods During AtrialFibrillation and Sinus Rhythm.
underlying atrialfibrillation or atrial inactivity). Details cannot be shared here, but suffice it to say that inability to recognize acute occlusive myocardial infarction in the presence of ventricular paced rhythm contributed to a poor outcome. After showing an ECG with paced rhythm that clearly shows acute MI, K.
Patient and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. Patient and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. Favorable discharge outcome occurred in 65.8% of all mild strokes and in 56.9%
Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS. Abnormal ECG – looks for cardiac syncope. Hemoglobin less than 10 (SF rule) 6. Syncope with Exertion (EGSYS) 7. S yncope while supine (EGSYS) 8.
Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrialfibrillation (AF) have been sparsely investigated. Objective To provide a contemporary prospective comparison of outcomes for newly diagnosed patients with AF, between Asian and non-Asian regions.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
75 
Let's personalize your content